- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03951701
Evaluation of Interest of a Systematic Screening for Oncological Supportive Care Needs (DBSOS)
Evaluation of Interest of a Systematic Screening for Oncological Supportive Care
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The study will unfold in the followed day hospital's departments of the Paul Strauss Cancer Center (Strasbourg, France) : supportive care department, chemiotherapy department and radiotherapy department. The study is based on two questionnaires that include six sections : nutrition, social, psychologic, physiotherapy, pain and supportive care needs evaluation.
The first questionnaire gives information about the patient and allow to screen supportive care needs. It should be read by medical or paramedical staff who report the function of the reader and options that are proposed to the patient after reading the questionnaire.
The second questionnaire will be done after 4 to 6 weeks by a phone call from the clinical research nurse. The objective of this questionnaire is to determine what kind of care have been provided.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Strasbourg, Frankrike, 67065
- Centre Paul Strauss
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patient treated for a cancer
- Age ≥ 18 years old
- Receiving treatment (chemotherapy and/or radiotherapy) in day hospital and/or supportive care department
- Able to speak, read and understand French
- Able to communicate by phone
- Written informed consent obtained from the patient
- Registration in a national health care system
Exclusion Criteria:
- Minor or protected adult
- Pregnant or breastfeeding woman
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: observation cohort
Questionnaire to assess the supportive care needs
|
Evaluation of interest of a systematic screening for oncological supportive care needs
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Evaluation of using oncological supportive cares after evaluation of supportive care needs reviewed by a professional of health, by a phone call
Tidsram: 4 to 6 weeks after baseline
|
Assess the percentage of using oncological supportive cares after evaluation of supportive care needs reviewed by a professional.
The use of supportive cares is evaluated with an hetero-questionnaire created for this study.
The hetero-questionnaire consists in a phone call to evaluate the evolution of each item of the self-assessment questionnaire (which includes 6 evaluations : a nutritional evaluation (10 items), a social evaluation (8 items), a psychologic evaluation (6 items), a physiological evaluation (7 items), a pain evaluation (4 items) and a supportive care needs evaluation (6 items)).
|
4 to 6 weeks after baseline
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Evaluation of initial supportive care needs by the self-assessment questionnaire
Tidsram: baseline
|
Assess the percentage of initial supportive care needs evaluated by the self-assessment questionnaire created for this study.
It includes evaluations : a nutritional evaluation (10 items), a social evaluation (8 items), a psychologic evaluation (6 items), a physiological evaluation (7 items), a pain evaluation (4 items) and a supportive care needs evaluation (6 items).
|
baseline
|
Assess the correlation between supportive care needs and age
Tidsram: This analyse will be realized at the end of the study (9 weeks after baseline)
|
Correlate the percentage of supportive care needs to age by a Pearson Chi squared test
|
This analyse will be realized at the end of the study (9 weeks after baseline)
|
Assess the correlation between supportive care needs and sexe
Tidsram: This analyse will be realized at the end of the study (9 weeks after baseline)
|
Correlate the percentage of supportive care needs to sexe by a Pearson Chi squared test.
|
This analyse will be realized at the end of the study (9 weeks after baseline)
|
Assess the correlation between supportive care needs and type of cancer
Tidsram: This analyse will be realized at the end of the study (9 weeks after baseline)
|
Correlate the percentage of supportive care needs to the type of cancer by a Pearson Chi squared test
|
This analyse will be realized at the end of the study (9 weeks after baseline)
|
Compare the percentage of using a supportive care professional judgement in regard to read and unread questionnaires by medical staff
Tidsram: This analyse will be realized at the end of the study (9 weeks after baseline)
|
Assess the percentage of using a supportive care when the medical staff read the completed questionnaire.
Assess the percentage of using a supportive care when the medical staff didn't read the completed questionnaire.
Then compare these values by using a T- test of Student.
|
This analyse will be realized at the end of the study (9 weeks after baseline)
|
Compare the percentage of using a supportive care professional judgement in regard to the function of the medical staff member
Tidsram: This analyse will be realized at the end of the study (9 weeks after baseline)
|
Assess the percentage of using a supportive care when the medical staff who read the completed questionnaire is a doctor, a nurse, or an auxiliary nurse .
Then compare these values by using a T- test of Student
|
This analyse will be realized at the end of the study (9 weeks after baseline)
|
Assess the percentage of requirement to the physician during the study
Tidsram: 4 to 6 weeks after baseline (by a phone call, at the same time than the hetero-questionnaire)
|
Assess the percentage of requirement to the physician during the study by asking each patient (by phone call)
|
4 to 6 weeks after baseline (by a phone call, at the same time than the hetero-questionnaire)
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Véronique FRASIE, Md, Centre Paul Strauss
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- 2018-02
- 2018-A01425-50 (Annan identifierare: ANSM)
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Stödjande vårdbehov
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekryteringCAR-T-terapikomplikationerItalien
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRekryteringPatientrapporterade resultatmått | CAR T-Cell terapiSchweiz
-
The Lymphoma Academic Research OrganisationNovartis; Gilead SciencesRekryteringHematopatologi Kvalificerad eller CAR-t-cellbehandlingFrankrike
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.Har inte rekryterat ännuAllogen, CAR-T, proteinsekvestrering, icke-genredigeradKina
-
Shanghai International Medical CenterOkändAvancerad solid tumör | PD-1 antikropp | CAR-T-cellerKina
-
Ningbo Cancer HospitalOkändAvancerade maligniteter | PD-1 antikropp | CAR-T-cellerKina
-
Ruijin HospitalRekrytering
-
Shanghai General Hospital, Shanghai Jiao Tong University...RekryteringCAR-T Cell | Ph Positivt ALLA | DasatinibKina
-
Insel Gruppe AG, University Hospital BernRekryteringVaccinimmunitet hos CAR-T-cellterapimottagareSchweiz
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRekryteringLångsiktig säkerhet för patienter som får CAR-T i en kvalificerad klinisk prövning eller Managed Access-programFörenta staterna, Japan, Australien, Tyskland, Spanien, Belgien, Taiwan, Italien, Kanada, Israel, Singapore, Storbritannien, Danmark, Finland, Norge, Österrike, Nederländerna, Frankrike
Kliniska prövningar på Evaluation of the supportive care
-
University Hospital, Clermont-FerrandOkänd
-
Memorial Sloan Kettering Cancer CenterAvslutadFamiljer eller anhöriga till patienter som behandlas vid MSKCC för icke-kutana skivepitelcancer i | Övre matsmältningskanalenFörenta staterna
-
Medical College of WisconsinAvslutadKommunikation | PatientengagemangFörenta staterna
-
Mustafa Kemalpasa Government HospitalAvslutadHyperemesis Gravidarum | Morgonillamående | TemperamentKalkon
-
Boston University Charles River CampusRekryteringMentala störningar | Sysselsättning | Anställning, Support | MetakognitionFörenta staterna
-
Canterbury Christ Church UniversityAvslutad
-
Hospices Civils de LyonRekrytering
-
Ankara Yildirim Beyazıt UniversityAvslutadOsteoporos | Hälsosam livsstil | UniversitetsstudenterKalkon
-
Skin Analytics LimitedAvslutadBasalcellscancer | Skivepitelcancer | Malignt hudmelanom T0Förenta staterna, Italien
-
Skin Analytics LimitedInnovate UKAvslutad